Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71401 - 71425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	LDLRAD4	753	downregulated	Silicon Dioxide analog results in decreased expression of LDLRAD4 mRNA	18p11.21	A24195
Silicon dioxide	Approved	LEF1	51176	upregulated	Silicon Dioxide results in increased expression of LEF1 mRNA	4q25	A24198
Silicon dioxide	Approved	LEFTY1	10637	downregulated	Silicon Dioxide analog results in decreased expression of LEFTY1 mRNA	1q42.12	A24195
Silicon dioxide	Approved	LEFTY1	10637	upregulated	Silicon Dioxide analog results in increased expression of LEFTY1 mRNA	1q42.12	A24194
Silicon dioxide	Approved	LEP	3952	downregulated	Silicon Dioxide analog results in decreased expression of LEP mRNA	7q32.1	A24194
Silicon dioxide	Approved	LEPR	3953	downregulated	Silicon Dioxide analog results in decreased expression of LEPR mRNA	1p31.3	A24195
Silicon dioxide	Approved	LETM1	3954	upregulated	Silicon Dioxide analog results in increased expression of LETM1 mRNA	4p16.3	A24195
Silicon dioxide	Approved	LETM2	137994	upregulated	Silicon Dioxide analog results in increased expression of LETM2 mRNA	8p11.23	A24195
Silicon dioxide	Approved	LFNG	3955	downregulated	Silicon Dioxide analog results in decreased expression of LFNG mRNA	7p22.3	A24195
Silicon dioxide	Approved	LGALS2	3957	downregulated	Silicon Dioxide analog results in decreased expression of LGALS2 mRNA	22q13.1	A24195
Silicon dioxide	Approved	LGALS4	3960	downregulated	Silicon Dioxide analog results in decreased expression of LGALS4 mRNA	19q13.2	A24195
Silicon dioxide	Approved	LGALS7	3963	downregulated	Silicon Dioxide analog results in decreased expression of LGALS7 mRNA	19q13.13	A24195
Silicon dioxide	Approved	LGALS9	3965	downregulated	Silicon Dioxide analog results in decreased expression of LGALS9 mRNA	17q11.2	A24195
Silicon dioxide	Approved	LGALS9C	654346	downregulated	Silicon Dioxide analog results in decreased expression of LGALS9C mRNA	17p11.2	A24195
Silicon dioxide	Approved	LGMN	5641	downregulated	Silicon Dioxide analog results in decreased expression of LGMN mRNA	14q32.12	A24195
Silicon dioxide	Approved	LGR6	59352	downregulated	Silicon Dioxide analog results in decreased expression of LGR6 mRNA	1q32.1	A24195
Silicon dioxide	Approved	LGSN	51557	downregulated	Silicon Dioxide analog results in decreased expression of LGSN mRNA	6q12	A24195
Silicon dioxide	Approved	LHFP	10186	upregulated	Silicon Dioxide analog results in increased expression of LHFP mRNA	13q13.3-q14.11	A24195
Silicon dioxide	Approved	LHFP	10186	upregulated	Silicon Dioxide results in increased expression of LHFP mRNA	13q13.3-q14.11	A24196
Silicon dioxide	Approved	LHFPL1	340596	upregulated	Silicon Dioxide analog results in increased expression of LHFPL1 mRNA	Xq23	A24195
Silicon dioxide	Approved	LHPP	64077	downregulated	Silicon Dioxide analog results in decreased expression of LHPP mRNA	10q26.13	A24195
Silicon dioxide	Approved	LHX4	89884	upregulated	Silicon Dioxide analog results in increased expression of LHX4 mRNA	1q25.2	A24195
Silicon dioxide	Approved	LHX9	56956	downregulated	Silicon Dioxide analog results in decreased expression of LHX9 mRNA	1q31.3	A24195
Silicon dioxide	Approved	LIAS	11019	downregulated	Silicon Dioxide results in decreased expression of LIAS mRNA	4p14	A24196
Silicon dioxide	Approved	LIF	3976	upregulated	Silicon Dioxide analog results in increased expression of LIF mRNA	22q12.2	A24195

Displaying entries 71401 - 71425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability